Skip to content

Virgin Coconut oil in the conservative management of Atrophic Rhinitis.

Evaluation of efficacy and safety of Virgin Coconut oil versus 25% Glucose in Glycerine in the management of Primary Atrophic Rhinitis; A comparative Prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047137
Enrollment
50
Registered
2022-11-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

Intervention1: Cold pressed Virgin Coconut oil: Food safety and standards authority of India Certified Cold pressed Virgin Coconut oil will be applied daily twice for six months to the nostril with t

Sponsors

Amrit Prakash
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 18 â?? 65 years. 2.Persons of either Sex. 3.He/she must be diagnosed & have symptoms of AR. 4.He/she must be willing to comply to study protocol till the end of trial. 5.He/she is willing to give written informed consent at the baseline visit.

Exclusion criteria

Exclusion criteria: 1.Patients with Secondary AR. 2.History of Hypersensitivity to Coconut products. 3.Patients who are either pregnant or lactating. 4.Patients with immunocompromised states like uncontrolled diabetes, History of recurrent/ Chronic infections, PLHA. 5.Patients receiving immunosuppressant therapy immune modulator therapy or chemotherapy. 6.History of nasal myiasis 7.Patients who are currently abusing or have a history of substance abuse.

Design outcomes

Primary

MeasureTime frame
1.Proportion of patients with subjective improvement in symptoms (disappearance of odour, dryness sensation, headache, nasal obstruction). 2.Incidence, Seriousness and severity of adverse events in the study population if any. Timepoint: The participants will be followed up 0.5, 1, 2, 4, and 6 months after the first visit

Secondary

MeasureTime frame
1.To Study the pattern of Microbial flora in Primary AR. 2.Corelation of Demographic parameters with the severity and outcome of the disease Timepoint: Nasal crusts / scrapping shall be taken at the end of 2nd and 6th months to evaluate the microbiome study changes

Countries

India

Contacts

Public ContactTrupti Rekha Swain

SCB Medical College and Hospital Cuttack 753007

drtruptiswain@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026